Published in Age (Dordr) on September 07, 2011
The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2012) 0.87
No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression. Eur Arch Psychiatry Clin Neurosci (2012) 0.82
Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms. J Psychiatr Res (2012) 0.81
Blood BDNF level is gender specific in severe depression. PLoS One (2015) 0.79
Mechanisms of extracellular signal-regulated kinase/cAMP response element-binding protein/brain-derived neurotrophic factor signal transduction pathway in depressive disorder. Neural Regen Res (2013) 0.77
Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents. Cereb Cortex (2016) 0.76
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
A Wilcoxon-type test for trend. Stat Med (1985) 13.22
Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex (2005) 9.73
A molecular and cellular theory of depression. Arch Gen Psychiatry (1997) 6.10
Recent developments and current controversies in depression. Lancet (2006) 5.42
Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A (1996) 5.24
Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry (2004) 5.10
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry (2000) 4.99
Why sex matters for neuroscience. Nat Rev Neurosci (2006) 4.75
The neurobiology of stress: from serendipity to clinical relevance. Brain Res (2000) 4.51
Neurotrophins and synaptic plasticity. Annu Rev Neurosci (1999) 4.01
Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry (2004) 3.83
The genetics of depression: a review. Biol Psychiatry (2005) 3.35
Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res (2002) 3.31
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J Neurosci (1995) 3.03
Hippocampal volume in geriatric depression. Biol Psychiatry (2000) 2.81
Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry (2008) 2.65
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry (2008) 2.35
Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry (2002) 2.15
BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry (2005) 2.00
Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med (2004) 1.94
Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci (2006) 1.85
Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc (2004) 1.69
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry (2005) 1.61
Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol (2005) 1.58
The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging (2005) 1.49
Depression: the case for a monoamine deficiency. J Clin Psychiatry (2000) 1.44
Hippocampal regulation of context-dependent neuronal activity in the lateral amygdala. Learn Mem (2007) 1.42
Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet (2003) 1.41
MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging (1998) 1.39
Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology (2006) 1.30
Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2008) 1.24
Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology (2003) 1.23
Stress and disease: is being female a predisposing factor? J Neurosci (2007) 1.18
Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry (2003) 1.10
Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet (2002) 1.05
Sexual dimorphism in the mammalian limbic system. Prog Neurobiol (1995) 1.04
Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet (2007) 1.03
Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol (2009) 1.02
Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. Am J Geriatr Psychiatry (2007) 1.02
Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav (2007) 1.01
The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport (2007) 1.01
Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. World J Biol Psychiatry (2011) 0.99
Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci (2010) 0.98
No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res (2006) 0.98
A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiatry (2011) 0.97
Measurement of precuneal and hippocampal volumes using magnetic resonance volumetry in Alzheimer's disease. J Clin Neurol (2010) 0.94
Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging (2008) 0.91
Gender differences in vulnerability to social stress: a Darwinian perspective. Physiol Behav (2001) 0.90
No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur Neuropsychopharmacol (2005) 0.88
Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm (Vienna) (2009) 0.88
Angiotensinogen M235T polymorphism and symptoms of depression in a population-based study and a family-based study. Psychiatr Genet (2008) 0.83
Intron-mediated RNA interference, intronic microRNAs, and applications. Methods Mol Biol (2010) 0.82
Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population. J Mol Neurosci (2010) 0.81
Monoamine metabolism in human brain. Arch Gen Psychiatry (1977) 0.80
An intronic variant in the TP53 gene in Serbian women with cervical or ovarian cancer. Cancer Genet Cytogenet (2010) 0.76
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet (2009) 4.11
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol (2008) 3.75
The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci (2010) 3.44
Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes (2004) 2.17
Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med (2004) 2.16
Who receives rehabilitation after stroke?: Data from the quality assurance project "Stroke Register Northwest Germany". Dtsch Arztebl Int (2013) 2.10
Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J (2008) 2.09
Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation (2008) 2.08
Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA (2004) 2.04
Healthy lifestyle and the risk of stroke in women. Arch Intern Med (2006) 2.02
The association between smoking and smell and taste impairment in the general population. J Neurol (2008) 2.01
Difference in recognition of right and left hemispheric stroke. Lancet (2005) 1.95
High-normal blood pressure is associated with poor cognitive performance. Hypertension (2008) 1.85
Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke (2003) 1.81
Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke (2003) 1.78
Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc (2004) 1.69
Smoking and risk of hemorrhagic stroke in women. Stroke (2003) 1.63
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
The quality of acute stroke care- an analysis of evidence-based indicators in 260 000 patients. Dtsch Arztebl Int (2014) 1.57
Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study. Cerebrovasc Dis (2010) 1.55
Neuroimmunological effects of physical exercise in depression. Brain Behav Immun (2011) 1.54
[A brief instrument for the assessment of childhood abuse and neglect: the childhood trauma screener (CTS)]. Psychiatr Prax (2012) 1.46
5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology (2007) 1.44
Incidence of migraine and tension-type headache in three different populations at risk within the German DMKG headache study. Cephalalgia (2011) 1.44
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. J Clin Psychiatry (2015) 1.39
Youth consultation-liaison psychiatry: how can we improve outcomes for young people with chronic illness? Aust N Z J Psychiatry (2013) 1.38
Regional and neighborhood disparities in the odds of type 2 diabetes: results from 5 population-based studies in Germany (DIAB-CORE consortium). Am J Epidemiol (2013) 1.35
Epidemiology of restless legs syndrome: the current status. Sleep Med Rev (2006) 1.32
A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol (2010) 1.30
Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med (2013) 1.28
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet (2011) 1.27
Incidence of restless legs syndrome in two population-based cohort studies in Germany. Sleep Med (2011) 1.26
Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med (2013) 1.23
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke. Stroke (2012) 1.22
Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study. J Psychiatry Neurosci (2007) 1.22
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet (2003) 1.22
A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke (2009) 1.20
Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology (2012) 1.19
Overweight and obesity at school entry among migrant and German children: a cross-sectional study. BMC Public Health (2005) 1.19
Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol (2008) 1.18
Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab (2008) 1.16
Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open (2012) 1.16
Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev (2011) 1.16
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Urban-rural disparities in smoking behaviour in Germany. BMC Public Health (2006) 1.14
Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology (2007) 1.13
Childhood maltreatment is associated with an automatic negative emotion processing bias in the amygdala. Hum Brain Mapp (2012) 1.12
Psychosis in Indigenous populations of Cape York and the Torres Strait. Med J Aust (2012) 1.12
Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord (2011) 1.12
Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol (2007) 1.11
Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. Acad Radiol (2008) 1.10
The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) (2011) 1.09
14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. Brain Res Mol Brain Res (2002) 1.09
Association between behavior-dependent cardiovascular risk factors and asymptomatic carotid atherosclerosis in a general population. Stroke (2002) 1.08
Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology (2011) 1.07
Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis. Ther Adv Endocrinol Metab (2010) 1.06
The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities. Biol Psychiatry (2012) 1.06
Free fatty acid receptors: emerging targets for treatment of diabetes and its complications. Ther Adv Endocrinol Metab (2010) 1.06
Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet (2005) 1.04
Stroke risk perception among participants of a stroke awareness campaign. BMC Public Health (2007) 1.03
Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology (2007) 1.03
The association between depressive mood and cognitive performance in an elderly general population - the MEMO Study. Dement Geriatr Cogn Disord (2006) 1.02
Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol (2009) 1.02
Changes in alcohol intake and risk of coronary heart disease and all-cause mortality in the MONICA/KORA-Augsburg cohort 1987-97. Eur J Cardiovasc Prev Rehabil (2004) 1.02
Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time. Stroke (2011) 1.02
Associations of socioeconomic status with migraine and non-migraine headache. Cephalalgia (2011) 1.02
Migraine and restless legs syndrome in women. Cephalalgia (2012) 1.01
Association between IL-8 cytokine and cognitive performance in an elderly general population--the MEMO-Study. Neurobiol Aging (2007) 1.01
Overweight, medical comorbidity and health-related quality of life in a community sample of women and men. Obesity (Silver Spring) (2009) 1.01
Cerebral changes on MRI and cognitive function: the CASCADE study. Neurobiol Aging (2006) 1.01
The relationship between psychological dimensions of depressive symptoms and cognitive functioning in the elderly - the MEMO-Study. J Psychiatr Res (2006) 1.01
Working-memory fMRI reveals cingulate hyperactivation in euthymic major depression. Hum Brain Mapp (2009) 0.99
Association between lifestyle factors and headache. J Headache Pain (2011) 0.98
Methodological quality of preclinical stroke studies is not required for publication in high-impact journals. J Cereb Blood Flow Metab (2010) 0.98
Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. Neuroimage (2009) 0.98
Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol (2009) 0.98
Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol (2004) 0.98
Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men. Hum Genet (2006) 0.98
Treatment wish of individuals with known and unknown restless legs syndrome in the community. J Neurol (2008) 0.97
Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Eur Neuropsychopharmacol (2008) 0.97
Joint effects of risk factors for stroke and transient ischemic attack in a German population: the EPIC Potsdam Study. J Neurol (2007) 0.97
Case report of MR perfusion imaging in sinking skin flap syndrome: growing evidence for hemodynamic impairment. BMC Neurol (2010) 0.96
The impact of the day of the week and month of admission on the length of hospital stay in stroke patients. Cerebrovasc Dis (2003) 0.96
Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol (2012) 0.96
Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. Age (Dordr) (2010) 0.96
Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study. Aging Cell (2013) 0.96